-+ 0.00%
-+ 0.00%
-+ 0.00%

BIOCRYST ANNOUNCES U.S. FDA APPROVAL OF ORLADEYO® 150 MG ORAL PELLETS FOR ADULTS AND ADOLESCENTS WITH HAE

Reuters·10/21/2026 11:02:47